US6465196B1

Drug screen for identifying an agent that modulates low density lipoprotein …

University of Texas System

Abstract

Low density lipoprotein receptor (LDRL) adaptin is a novel, key component of human cholesterol regulation, which provides a target for rational drug design and screening, therapeutic intervention, and diagnosis. Disclosed reagents include a variety of LDLR adaptin and LDLR adaptin PTB and CC …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Helen H. Hobbs
Priority date: March 13, 2001
Filing date: March 13, 2001
Grant date: October 15, 2002
Publication date: October 15, 2002
Language: en
PDF source: https://patentimages.storage.googleapis.com/59/64/be/fa165a302adf64/US6465196.pdf
Metadata fetched: August 28, 2026 23:57